AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00
- £126.31m
- £122.64m
- £59.59m
RCS - Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics shares positive new data
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Secures new revolving credit facility
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - FDA clearance of IND application for VLP Peanut
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - Allergy Therapeutics - Half Year Trading Update & Notice of Results
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics: Granting of Awards
AnnouncementREG - Allergy Therapeutics - Result of AGM
AnnouncementREG - Allergy Therapeutics - Director Dealings
AnnouncementREG - Allergy Therapeutics - Cheryl MacDiarmid appointed to Board of Directors
Announcement